Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
   
   

The present invention provides novel bridged beta-carboline compounds that are capable of inhibiting mitogen activated protein kinase-activated protein kinase-2 and analogues thereof and pharmaceutical compositions and kits that include these compounds.

 
Web www.patentalert.com

< Pharmaceutical compositions and methods for treating, preventing, and managing cholesterol, dyslipidemia, and related disorders

< Therapeutic treatment methods 2

> Antibody diversity generation

> Modulators of peroxisome proliferator activated receptors
~ 00180